14:01 EDT GeoVax sees Gedeptin technology as potentially applicable to any solid tumor
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOVX:
- GeoVax Labs Announces $6 Million Public Offering
- GeoVax’s EMA guidance provides clear pathway, says Alliance Global Partners
- Closing Bell Movers: Solar stocks fall on tax credit threat
- GeoVax Labs files to sell 6.15M common units
- GeoVax Labs receives favorable European regulatory guidance supporting GEO-MVA